As a PhD researcher in Molecular Biology and Genetics, my academic interests lie in the investigation of inflammation-related molecular pathways, metabolic syndrome markers, and antimicrobial resistance. I have a strong focus on the role of NAMPT, Vaspin, and IL-6 in chronic inflammation, obesity, and metabolic dysfunctions.
During my doctoral training, I have worked on multidisciplinary projects that combine molecular biology, biochemistry, immunology, and microbiology. In addition to my work on inflammation and adipokine signaling, I have investigated the antimicrobial properties of plant-based nanoemulsions against drug-resistant pathogens such as Helicobacter pylori. This dual research line has allowed me to explore both the immunometabolic and therapeutic aspects of molecular biology.
My long-term academic goal is to contribute to the development of novel diagnostic and therapeutic approaches targeting inflammatory and metabolic pathways. I am particularly interested in translational research that bridges basic science with clinical application, especially in the context of metabolic and infectious diseases.
As a PhD researcher in Molecular Biology and Genetics, my academic interests lie in the investigation of inflammation-related molecular pathways, metabolic syndrome markers, and antimicrobial resistance. I have a strong focus on the role of NAMPT, Vaspin, and IL-6 in chronic inflammation, obesity, and metabolic dysfunctions.
During my doctoral training, I have worked on multidisciplinary projects that combine molecular biology, biochemistry, immunology, and microbiology. In addition to my work on inflammation and adipokine signaling, I have investigated the antimicrobial properties of plant-based nanoemulsions against drug-resistant pathogens such as Helicobacter pylori. This dual research line has allowed me to explore both the immunometabolic and therapeutic aspects of molecular biology.
My long-term academic goal is to contribute to the development of novel diagnostic and therapeutic approaches targeting inflammatory and metabolic pathways. I am particularly interested in translational research that bridges basic science with clinical application, especially in the context of metabolic and infectious diseases.